SUMMARY The neutral, metal dependent, proteoglycan degrading enzymes (NMPEs) in human osteoarthritic knee cartilage homogenates were activated by p-aminophenylmercuric acetate (APMA). The resultant effect on the structure of newly synthesised and already existing sulphated proteoglycan was measured. Newly synthesised and already existing proteoglycan aggregated to hyaluronic acid was reduced (p<0-01, p<0-05 respectively) when measured by chromatography on Sepharose CL-2B eluted with associative buffer. The APMA activated enzyme affected both the newly synthesised and already existing proteoglycan aggregate similarly (r=0-79, p<0001). Treatment of cartilage homogenates with APMA and 1,10-phenanthroline (10 mM) showed that the amount of aggregated proteoglycan was at the control level. The hydrodynamic size of the proteoglycan monomer (AlD1) was also reduced by treatment of cartilage homogenates with APMA. Reaggregation experiments with fraction AlDl and exogenous hyaluronic acid and link protein showed a similar defect in forming proteoglycan aggregates. These data showed that activation of the NMPEs altered the structure of proteoglycan in two ways. The most consistent change was a reduction in the ability of proteoglycan to form aggregates with hyaluronic acid. This was likely to have occurred via a cleavage of the core protein in or around the hyaluronic acid binding globular domain. A second alteration probably includes a limited proteolytic cleavage in the remainder of the core protein.
units) may diffuse out of the extracellular matrix, aggregated proteoglycans cannot.9 Thus maintenance of proteoglycans in the aggregated state is essential to enable cartilage to resist compressive mechanical forces and provide proper joint compliance. 11 Any changes in the already existing proteoglycan aggregates as a result of mechanical transducing signals or increased NMPE levels, or both, would be expected to reduce the amount of tissue proteoglycan. Indeed, one of the earliest histopathological changes in osteoarthritic cartilage is a loss of metachromasia.12 If the chondrocytes were able to synthesise increased amounts of proteoglycan and replace the resorbed molecules, however, it is conceivable that cartilage integrity could be maintained.
Several recent studies from our laboratories'3 14 (Shuckett et al, unpublished data) and from others'5 16 have dispelled the previously held concept that chondrocytes of osteoarthritic cartilage fail to synthesise functional proteoglycans. Thus remaining alternatives must include the hypothesis that newly synthesised proteoglycan bearing a functional hyaluronic acid binding region (HABR) that allows for aggregation to hyaluronic acid is degraded by activated proteolytic enzymes before forming supramolecular structures. It has recently been shown that proteoglycan catabolism of mature rabbit cartilage maintained in serum involves proteolysis of the core protein and a separation of the hyaluronic acid bind region from the glycosaminoglycan-rich regions.16a This hypothesis was studied in knee cartilage derived from the lateral tibial plateau of patients undergoing total joint arthroplasty for debilitating OA. The changes in the structure of the already existing proteoglycans were compared with those of the newly synthesised proteoglycans radioisotopically labelled with 35 o4 by short term (24 hours), organ explant culture.17
The effect on proteoglycan structure of activating the endogenous latent cartilage NMPEs with paminophenylmercuric acetate (APMA) was assessed. The tissue was rinsed and placed in a culture dish (60 mmx 15 mm; Falcon Plastics) for 24 hours at 37°C in a Dulbecco's modified Eagle's medium (high glucose) containing 10% fetal bovine serum (Gibco Laboratories, Burlington, ON, Canada), antibiotics, and Na235SO4 (0.37-37 GBq/mmol sulphur; New England. Nuclear, Canada) at a concentration of 0-74 GBq/l. At the end of the incubation period the tissues were washed and processed immediately.
ENZYME MEASUREMENT
The tissue samples were homogenised in trometamol (TRIS) buffer (50 mM trometamol HCl, 150 mM NaCl, 10 mM CaCl2, 80 ig gentamycin) pH 7-4 and divided into three separate groups: group 1 was incubated for 42 hours at 37°C; group 2 tissue was treated with APMA (1 mM) and incubated for an identical time; group 3 tissue was incubated with APMA followed by 1,10-phenanthroline (5 mM). Total NMPE was measured as previously described.6 Briefly, the enzyme activity in an aliquot of the cartilage homogenates was obtained by measuring proteoglycan released from a complex of proteoglycans, their digested products, and cetylpyridinium chloride. The digested products were selectively released with trichloroacetic acid and measured by their hexuronic acid (HexA) content. 20 The enzyme activity was expressed as a percentage of the HexA released. All values for non-enzymatic release of proteoglycan were corrected. This was obtained during the 42 hour incubation period by keeping an aliquot of the homogenate at 4°C.
Enzyme activity in the group 1 samples measures the already active (constitutive) NMPE of cartilage. Total NMPE was measured by the digestion found in the cartilage homogenates incubated in the presence of APMA minus that found in the APMA plus 1,10-phenanthroline incubations (i.e., group 2 minus group 3).
PROTEOGLYCAN EXTRACTION
A modification of the extraction procedure de-scribed by Oegema et al was used.2' Proteoglycans were extracted for 24 hours at 4°C in 20 ml of 4 M guanidine-HCl, 50 mM sodium acetate buffer, pH 5-8, which contained several protease inhibitors (100 mM 6-aminohexanoic acid, 10 mM disodium edetate, 5 mM phenylmethanesulphonyl fluoride, and 5 mM benzamidine hydrochloride). The extract was centrifuged at 12 000 g for 30 minutes and the supernatant dialysed exhaustively at 4°C in Spectrapor membranes (2000 molecular weight cut off) against distilled water and freeze dried. The cartilage residue was washed with distilled water and incubated at 65°C for five hours with papain 1 ,ug/mg of original tissue wet weight) in sodium phosphate buffer, pH 6-5. The HexA and 35 o4 radioactivity levels were measured on the supernatant to determine the efficiency of the 4 M guanidine-HCI extraction.
CHARACTERISATION OF PROTEOGLYCANS

Ultracentrifugation analysis
The extracted freeze dried proteoglycans were first dissolved in 50 mM sodium acetate buffer, pH 5.8, containing 0.5 M guanidine-HCl. Density gradient ultracentrifugation, under associative conditions, was performed as previously described.22 Gradient fractions designated Al to A4, based on their isopyknic densities, were obtained.
Aliquots of the Al fraction were processed under dissociative conditions.22 Four equal fractions designated AlDl (Q=>1-6 g/ml) to A1D4 (Q=1-4 g/ml)
by final isopyknic density were obtained.
Chromatographic analyses Gel filtration chromatography was carried out along the lines of methods previously published.22 In brief, the Al fraction was chromatographed on a Sepharose CL-2B column (0.4 cmx117 cm), equilibrated with 500 mM sodium acetate buffer, pH 7-0. Fractions of 0-5 ml were collected.
The AlDl fraction was chromatographed under dissociative conditions (4 M guanidine-HCl, 500 mM sodium acetate, pH 5.8) on a Sepharose CL-2B column (0-8 cmx 116 cm). Fractions of 1-0 ml were eluted. The glycosaminoglycan chain size was measured after reduction with NaBH4 and chromatography on Sepharose CL-6B.22 23 Proteoglycan monomer-hyaluronic acid interactions The reaggregation procedure was carried out as previously described. '4 Analytical study The HexA measurement was determined by the carbazole method20 and was used as an index of endogenous proteoglycan content. Associative CsCl density gradient Table 1 shows the distribution of HexA and 35So4. In all groups the amount of newly synthesised proteoglycan exceeded that of the macromolecules containing HexA in the most dense Al fraction (p<0.002). In contrast, the already existing macromolecules containing HexA of middle density (A2 and A3) exceeded in amount that of the newly syntheAised proteoglycans and reached statistical significance in A2 (p<0002). No differences were seen in the least dense A4 fraction. These results also showed that no differences existed between the groups in the distribution of either HexA or 35 o4. Gel filtration Fig. 1 shows a A linear regression analysis (Fig. 3) was carried out to assess whether the newly synthesised proteoglycan and already existing proteoglycan were affected to the same extent by the treatments. These results confirmed that the 35S04-containing and already existing proteoglycan aggregate were affected to the same extent.
Dissociative CsCI gradient Fraction Al was subjected to CsC1 density gradient centrifugation to assess whether APMA treatment affected the density of proteoglycan subunits associated with either hyaluronic acid (void volume peak) or the retarded peak on Sepharose CL-2B. The distribution of 35S04 and HexA were unaffected by APMA. No differences existed between the groups in the percentage of high density AlDl fraction (86-8-92.7% of the total) or in fractions of middle (A1D2, A1D3) or low density (A1D4).
Fraction AlDl hydrodynamic size The size of the high density proteoglycan monomer after treatment of cartilage homogenates with APMA was studied ( Table 2 ). There was a statistically significant decrease in the hydrodynamic size of the AlDl fraction of both the newly synthesised component (p<002) and the already existing proteoglycan (p<001) when group 2 results were compared with those for group 1. This increase in K,v was not seen when APMA extracts were treated with 1,10-phenanthroline (group 3). APMA failed to alter the glycosaminoglycan chain size (Ka5=0.58, 35S04; 0O62, HexA) (Fig. 4) . Reaggregation of AIDJ fraction Fig. 4 Sepharose CL-6B chromatography of isolated newly synthesised (35SO4) and HexA-containing glycosaminoglycans derivedfrom the CsCI density gradient fraction AJDIJ. The hydrodynamic size ofthe newly synthesised glycosaminoglycans is slightly larger than those endogenous to osteoarthritic cartilage. APMA did not alter the elution profile. These aggregates are essentially fixed within the extracellular matrix of articular cartilage. The present study showed that the constitutive NMPE activity in osteoarthritic cartilage was incapable of altering the amount of either newly synthesised or tj group.bmj.com on June 14, 2017 -Published by http://ard.bmj.com/ Downloaded from endogenous proteoglycan aggregates. Activation of the mostly latent enzyme, however, reduced the amount of newly synthesised and already existing proteoglycan aggregate as well as the hydrodynamic size of the proteoglycan monomer itself.
The fact that activation of the NMPEs did not alter glycosaminoglycan chain size, or result in a marked redistribution of proteoglycan when analysed by density gradient centrifugation, indicated that core protein proteolysis was rather limited. Noteworthy was the finding that the newly synthesised and the already existing proteoglycan population were affected similarly. Thus these results support the conclusion that synthesis of proteoglycans occurs in a normal fashion in osteoarthritic cartilage, and substantiates the contention that activated NMPE cleaves the core protein before acquiring high affinity binding for hyaluronic acid.
The formation of proteoglycan aggregates has been thought to reduce proteolytic cleavage of the core protein. 24 25 Recent studies, however, have shown the presence of the HABR associated with hyaluronic acid in the absence of the chondroitin sulphate attachment region,26 and this together with the present data suggests that proteolytic cleavage may occur distal to the HABR itself, releasing the bulk of core protein. Thus the present data support at least two possible interpretations. The activated NMPE may cleave the core protein before the formation of stable proteoglycan aggregates (see above). This is probably the case with the newly synthesised proteoglycans. It is equally possible that proteolytic cleavage occurs in proteoglycans already aggregated to hyaluronic acid.
The NMPE is favoured as the major contributor to the disaggregation and further cleavage of proteoglycans in the interterritorial region.6 Acid metalloproteinases may also participate in the pericellular region27 as well as in the interterritorial matrix as at least some of the acid enzyme activity (40%) is retained near neutral pH. Moreover, increased active enzyme was associated with fibrillation. As it is likely that a significant proportion of the superficial cartilage is eroded in OA the total NMPE concentrations in the present study (7.3 (SEM 0.6)%) compare favourably with those measured in cartilages taken at necropsy from patients older than 50 years. 31 Reaggregation experiments in which purified AlDl was incubated with hyaluronic acid helped resolve one contentious component of this study. In the specimens that received no addition and in those treated with 1,10-phenanthroline the amount of reaggregated proteoglycan (Fig. 5 ) slightly exceeded the value reached by equilibrium dialysis. The reduced proteoglycan aggregate formation seen in the AMPA treated samples (Fig. 2) could have occurred if insufficient hyaluronic acid were present in the original homogenate. The amount of proteoglycan aggregates formed by reaggregation and by dialysis were similar, however. Any differences in proteoglycan aggregation obtained in this study and in the previous one14 may reflect additional postmaturational changes in the HABR (i.e., additional 42 hours). Thus the most attractive explanation to account for these results is that some proteoglycan monomers do not possess the capacity to form aggregates. Presumably a missing HABR or a nonfunctional HABR accounts for this.
The pathophysiological consequences of reductions in the size of the proteoglycan monomer have yet to be established. Based on the calculations of Ohno et al,32 the newly synthesised proteoglycan monomer AlDl from group 1 ( Table 2) These present findings suggested that activators of the latent metalloenzymes are either inhibited in situ or are not synthesised even in cartilage of patieints with severe OA. Putative activators of NMPE in vivo (plasmin?) would appear to be intimately involved in the alteration of the newly synthesised and endogenous proteoglycans. In this regard, marked synovial involvement occurring early in experimental canine OA34 (and presumably occurring at some time in the continuum of human OA) resulted in complete absence of proteoglycan aggregates and apparent multiple cleavages of the core protein. 35 The present results suggest that therapeutic intervention designed to inhibit NMPE activators may significantly limit the progressive aspect of osteoarthritic cartilage destruction.
